Search:

China Gene Chip Market

Report Overview

Since the first genechip product was designed by Affymatrix in 1992, genechip has been widely used in various areas, i.e. clinical diagnosis, scientific research, drug developing, military application, forensic identification, health management, sport medicine, animal and plant quarantine, food quality inspection, environmental monitoring, etc, and the application in clinical diagnosis, especially in the personalized cancer treatment has bright prospects in future, with the technology of genechip, personalized treatment is able to carry out, medication efficacy and patient survival rate will be increased, at the meantime, overall cost will be reduced.

In China, next to the huge market in heritage genetic disease diagnosis and infectious disease diagnosis, Genechip also has great market potential in cancer diagnosis and individualized therapy, the 1st upcoming markets will be on breast cancers and lung cancers.

This report focuses on the analysis of genechip application in personalized cancer treatment, which covers information on industry supporting policies, market landscape, potential market growth and main competitors to sum up the present status and point out the future business opportunities.

Key Report Features

Size of global and Chinese genechip market

Projection of market size and growth

Applications of gene chip on clinical diagnosis: genetic diseases, infectious diseases and cancers

Macro policy of the government, planning and vision, initiatives, sponsorship programs and status of development

Regulatory affairs & product registration

Key domestic players, portfolio and pipeline, applications in clinical practice, indications and prices

Key international players, marketed products in China, applications in clinical practice, indications and prices

The report is about 26 pages in presentation format, both Chinese and English versions are available, but will charge separately.

Who Would Benefit From This Report?

CEOs

Sales & Marketing VPs

R & D

BD/Marketing/ Medical Directors

Researchers

Financial Analysts in pharmaceutical, medical device, health food, cosmetics

Private and institutional investors in life science industry

Publication date

July 1st, 2012

Price

5,000 RMB or 800 USD per subscription.

*You can send E-mail Email to LFE to purchase this report.

Please transfer the RMB or USD payments to the following account:

A/C: Shanghai Loudon Marketing Consultant Co., Ltd
A/C: No. 444259223258
Bank Name: Bank of China Shanghai, FanYu Road Sub-branch
Swift code: BKCHCNBJ300

Name Beneficiary：Loudon Far East B.V. The Netherlands
Bank Name：ING Bank N.V.
Account No：67.38.48.906
IBAN：NL23INGB 0673848906
BIC/SWIFT：INGBNL2A

Step 1:

Please choose the report you are interested in, click "More information" button.

Step 2:

Please go through the brief introduction of the report carefully and click "E-mail" link in the end of the page.

Step 3:

Please finish filling your required information in the e-mail.

Step 4:

After sending E-mail to Loudon, our client service person will contact you afterwards.

*If any questions, please contact our client service person.

Tel: +86-21-6290 2121-107

Email: jenny.zhu@loudon-research.com

(All free during 10:00~18:00 every work-day)